Recharge Your Job Search in 2018. AARP Foundation Can Provide You With Resources and Training. Learn More

Reply
Recognized Social Butterfly

Re: Would you consider the shingles vaccine?

748 Views
Message 21 of 38

GailL1 wrote:

 Talk to your doc about this one -'since it is (2) doses, I have no idea of the price -

hopefully it will be listed on formularies for 2018.  

 

I will ill check my coverage when I get a minute ( maybe after Thanksgiving).  Seems they are preferencing Shingrix over Zostavax and are recommending people get the new one even if they have gotten the other one - maybe after 5-years or so when Zostavax seems to lose some of its power.


I recently inquired at two different part D prescription plan companies about the Shingrix vaccine and both said they were intending to take a longer look at the Shingrix vaccine study and I guess probably the associated price too before they decide whether or not they will add it to their formularies in 2018. It’s just too new of a vaccine because when I typed Shingrix into the formulary search neither company documented it, but the phone reps knew about it.

 

They had no problem with the Zostavax vaccine its available any time with a $46 copay.

 

The CDC or FDA has suggested as long as it’s been 8 weeks between the Zostavax and Shingrix vaccine it shouldn’t be a problem but to check with your own doctor about your immune system. It’s been reported that after 5 years the Zostavax vaccine is only 35 percent effective.

Report Inappropriate Content
Valued Social Butterfly

Re: Would you consider the shingles vaccine?

793 Views
Message 22 of 38

sb4053877 wrote:

I currently have post herpetic neuralgia from shingles.  

Is this new vaccine made with a live virus?  That is the reason my doctor advised AGAINST the previous vaccine.

Is this new one made with LIVE VIRUS?


No, it is NOT live - it is a non living viral particle.

There are (2) doses given a few weeks apart.

 

There are key differences between the way Shingrix and Zostavax are designed. The new shingles vaccine contains an adjuvant, a substance that boosts the immune system’s response. This may be what makes Shingrix both more effective and longer-lasting, says Schaffner at Vanderbilt.

 

Unlike Shingrix, Zostavax contains live—although weakened—herpes zoster virus, so those with significantly weakened immune systems should not receive it. But because the new shingles vaccine contains a nonliving viral particle, it may ultimately be deemed appropriate for those with compromised immunity.

 

Consumer Reports,11/01/2017'-'New Shingles Vaccine FAQ

 

This was just the 1st reference which I found - there are many more -'some scientific, others for the layperson.

 

Talk to your doc about this one -'since it is (2) doses, I have no idea of the price -

hopefully it will be listed on formularies for 2018.  

 

I will ill check my coverage when I get a minute ( maybe after Thanksgiving).  Seems they are preferencing Shingrix over Zostavax and are recommending people get the new one even if they have gotten the other one - maybe after 5-years or so when Zostavax seems to lose some of its power.

Report Inappropriate Content
Info Seeker

Re: Would you consider the shingles vaccine?

762 Views
Message 23 of 38

I currently have post herpetic neuralgia from shingles.  

Is this new vaccine made with a live virus?  That is the reason my doctor advised AGAINST the previous vaccine.

Is this new one made with LIVE VIRUS?

Report Inappropriate Content
Valued Social Butterfly

Re: Would you consider the shingles vaccine?

736 Views
Message 24 of 38

sestanton1 wrote:

Unfortunately, I am on a tight, fixed income and cannot afford the shot. My pharmacist said my part of the cost would be $200. Seems like a small amount

to pay for prevention, but not on my budget, although I have Medicare Supplemental insurance.  


It is covered by Part D - your prescription drug plan.  It is NOT covered by Medicare Part A or Part B thus your supplemental has nothing to do with it.

 

Find out how much your portion of the shingles shot you will have to pay if you go to a preferred pharmacy on your plan.

 

Make sure you tell them you want the newest one - it is better and I assume it is already on the market.  Zostavax is the old one, Shingrix is the new and better med

 

Are you eligible for "EXTRA HELP"?

 

 

Report Inappropriate Content
Info Seeker

Re: Would you consider the shingles vaccine?

736 Views
Message 25 of 38

Unfortunately, I am on a tight, fixed income and cannot afford the shot. My pharmacist said my part of the cost would be $200. Seems like a small amount

to pay for prevention, but not on my budget, although I have Medicare Supplemental insurance.  

Report Inappropriate Content
Info Seeker

Re: Would you consider the shingles vaccine?

746 Views
Message 26 of 38

Yes

Report Inappropriate Content
Info Seeker

Re: Would you consider the shingles vaccine? YES!

957 Views
Message 27 of 38
Misdinosed at hospital had pain for 14 years. Will shot help
Report Inappropriate Content
Info Seeker

Re: Would you consider the shingles vaccine? YES!

1,477 Views
Message 28 of 38

We baby boomers all had "shots" as a child. Immunizations are very important to babies and adults. Why would you NOT get the vaccine? Preventive medicine is very important in these times of contatagious viruses. I want to do all I can to protect myself from everything possible.

Report Inappropriate Content
Recognized Social Butterfly

Re: Would you consider the shingles vaccine?

1,431 Views
Message 29 of 38
Report Inappropriate Content
Valued Social Butterfly

Re: Would you consider the shingles vaccine?

1,496 Views
Message 30 of 38

Thanks, AARPLynn,

Yes, some stuff does get by me - this is good to know for several reasons

 

From your link:

 GlaxoSmithKline said the price of its shingles vaccine, called Shingrix, will be $280 for the required two shots. Merck & Co.'s one-shot Zostavax costs $223. Most insurance plans cover it.

 

Now that there is competition - perhaps the price will come down but since it seems the new one is better (?) the price for this one might stay high or go higher if the demand is there.

 

I don't think this new vaccine would have ever been developed except for the money which Merck reportedly made off Zostavax especially since Medicare promoted it as well as the CDC.

 

. . . . and it has a better (?) efficacy rate than Zostavax -

 

Zostavax reduced the incidence of herpes zoster by 70% in 50–59-year-olds, by 64% in 60–69-year-olds and by 38% in people aged 70 and older in its pivotal trials. Shingrix vaccine provided 97% protection against herpes zoster in patients aged 50 years and over.

 

The new one (Shingrix) ia also a non-live, recombinant subunit vaccine.  This differs from Zostavax which is a live vaccine and where prep and injection route by the pharmacy giving it is imperative.  That's the reason my doc would not give me an Rx - he said for these specification, he wanted to make sure it was given correctly so I had it in his office.  Zostavax was given subcutaneously, Shingrix is give intramuscular.

 

This sounds great all the way around -

 

Thanks for the heads up.

 

 

 

 

Report Inappropriate Content